Insight on Healthcare

Published within

« | 1 | 2 | 3 | 4 | 5 | » »|

Type Product title / description Pub Price
Report
Report

5EU: Pricing, Reimbursement and Regulatory Update

Datamonitor’s report 5EU: Pricing, Reimbursement, and Regulatory Update provides an overview of developments regarding healthcare reforms, drug regulation, and drug pricing and reimbursement in France, Germany, Italy, Spain, and the UK.

Published By Datamonitor
28 Oct 2011 $1520
Buy
Report
Report

Biosimilars: China Update

Biosimilars: China Update provides analysis on the Chinese biogenerics market. It includes an overview of drivers and resistors to biogeneric uptake, market access strategies, key biogeneric players and future development trends.

Published By Datamonitor
22 Sep 2011 $1520
Buy
Report
Report

Biosimilars: India Update

Biosimilars: India Update provides analysis on the Indian copy biologics market. It includes an overview of drivers and resistors to biologic uptake, market access strategies, key domestic biologic players and future development trends.

Published By Datamonitor
14 Oct 2011 $1520
Buy
Report
Report

Biosimilars: Japan Update

Datamonitor’s report Biosimilars: Japan Update provides analysis on the Japanese biosimilars market. It includes an overview of drivers and resistors to biosimilars uptake, market access strategies, key players, and future development trends.

Published By Datamonitor
13 Sep 2011 $1520
Buy

Exclusive online offer: order this report by November 9th and save 20%

To take advantage of this offer enter Promo Code BIO2012 when prompted in the checkout

More information

Report
Report

Biosimilars: Market Entry Strategies

This report provides an analysis of strategies employed by the top 50 pharma companies that are active or plan to enter the biosimilars sector in the future, together with an analysis of biosimilar deal trends among the top 50 pharma companies.

Published By Datamonitor
20 Dec 2011 $2800
Buy
Report
Report

Biosimilars: Pipeline Trends

The report provides an overview of biosimilar and copy-biologic product landscape, split by marketed and pipeline products, target therapy areas and indications, geography, and drug developers.

Published By Datamonitor
09 Dec 2011 $2800
Buy
Report
Report

Biosimilars: Regulatory Update

Datamonitor’s report Biosimilars: Regulatory Update provides analysis on key developments in biosimilar regulations globally. It includes an overview of the background behind these events and popular strategic responses.

Published By Datamonitor
08 Dec 2011 $1520
Buy
Report
Report

Biosimilars: Regulatory Update

Datamonitor’s report Biosimilars: Regulatory Update provides analysis on key developments in biosimilar regulations globally.

Published By Datamonitor
09 Aug 2011 $1520
Buy
Report
Report

Brazil Pharmaceutical Market Overview – Strong market growth continues, but regulatory risks increase

Overview of the pharmaceutical market in Brazil including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis, and pharmaceutical market and pharmaceutical company infrastructure analysis.

Published By Datamonitor
21 Sep 2012 $2800
Buy
Report
Report

Canada: Generics and Biosimilars Overview

Overview of the generics and biosimilars landscape including, regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.

Published By Datamonitor
03 Nov 2011 $1520
Buy

« | 1 | 2 | 3 | 4 | 5 | » »|

No help is available.